About Biovalence Technologies
Biovalence Technologies is a Healthcare company based in Singapore (Singapore) founded in 2011 by Alfred Chua. It delivers advanced genomics and proteomics solutions to develop innovative antiviral therapies for infectious diseases. It operates on a B2B model. Its chief executive, as recorded, is Alfred Chua. Its focus areas include Biotechnology, Therapeutics Development and Antiviral Solutions. Its legal entity in India is Biovalence Technologies Llp (AAE-2692).
Company details
Biovalence Technologies, established in 2011, excels in providing healthcare solutions, advancing biotech innovations, therapeutics development, and antiviral solutions. Delivers advanced genomics and proteomics solutions to develop innovative antiviral therapies for infectious diseases. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
- Headquarters Singapore, Singapore
- Founders Alfred Chua
- SectorsHealthcare
- Website biovalence.com
- Legal Name Biovalence Technologies Llp
- Date of Incorporation 26 Jun, 2015
- Jurisdiction Patna, Bihar, India
Associated legal entities of Biovalence Technologies
Biovalence Technologies operates through Biovalence Technologies Llp (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Biovalence Technologies Llp CIN AAE-2692 | Active | 26 Jun 2015 | Patna, Bihar | 2 | View details |
Board of directors of Biovalence Technologies Llp (Biovalence Technologies)
Biovalence Technologies Llp is the primary company behind Biovalence Technologies. The board of Biovalence Technologies Llp currently have 2 directors; the longest-serving is Arvind Kumar Sharma, appointed in 2015.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Arvind Kumar Sharma DIN 07190165 | Designated Partner | 26 Jun 2015 | 11 yrs 4 mo | Biovalence Technologies Llp |
| Deepak Sharma DIN 06854644 | Designated Partner | 26 Jun 2015 | 11 yrs 4 mo | Biovalence Technologies Llp |
People of Biovalence Technologies
1 people are tracked at Biovalence Technologies (1 in leadership).
| Name | Role | Group |
|---|---|---|
Alfred Chua | Founder, CEO | Leadership |
Complete people profiles for Biovalence Technologies
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Biovalence Technologies
Biovalence Technologies was founded in 2011.
Biovalence Technologies is headquartered in Singapore, Singapore.
Alfred Chua is the CEO of Biovalence Technologies, as recorded in our data. They have also founded this company.
Biovalence Technologies, established in 2011, excels in providing healthcare solutions, advancing biotech innovations, therapeutics development, and antiviral solutions. Delivers advanced genomics and proteomics solutions to develop innovative antiviral therapies for infectious diseases. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
Biovalence Technologies operates through Biovalence Technologies Llp.
The legal entities of Biovalence Technologies currently have 2 directors, including Arvind Kumar Sharma, Deepak Sharma.